Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels. (Q48644420)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22790794%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22790794%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22790794%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

5

Hugo A Katus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22790794%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Constanze Schmidt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22790794%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Patrick A Schweizer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22790794%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Rüdiger Becker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22790794%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Dierk Thomas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22790794%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

13 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22790794%20AND%20SRC:MED&resulttype=core&format=json

Naunyn-Schmiedeberg's Archives of Pharmacology

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22790794%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

385

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22790794%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

1003-1016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22790794%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22790794%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00210-012-0780-9

7 February 2020

exact match

0 references

cites work

Effects of dronedarone on acetylcholine-activated current in rabbit SAN cells

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

The TASK family: two-pore domain background K+ channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Effect of dronedarone on Na+, Ca2+ and HCN channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Crystal structure of the human K2P TRAAK, a lipid- and mechano-sensitive K+ ion channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Dronedarone in High-Risk Permanent Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Characterization of TASK-4, a novel member of the pH-sensitive, two-pore domain potassium channel family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Knock-out of the potassium channel TASK-1 leads to a prolonged QT interval and a disturbed QRS complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

New antiarrhythmic drugs for treatment of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Functional role of TASK-1 in the heart: studies in TASK-1-deficient mice show prolonged cardiac repolarization and reduced heart rate variability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Clinical pharmacology of dronedarone: implications for the therapy of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Atrial-selective approaches for the treatment of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Novel approaches for pharmacological management of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Does sumoylation control K2P1/TWIK1 background K+ channels?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Electrophysiologic characterization of dronedarone in guinea pig ventricular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Regulation of two-pore-domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

The human cardiac K2P3.1 (TASK-1) potassium leak channel is a molecular target for the class III antiarrhythmic drug amiodarone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Identification and functional characterization of zebrafish K(2P)10.1 (TREK2) two-pore-domain K(+) channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

TREK-1 K(+) channels in the cardiovascular system: their significance and potential as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Two-pore potassium channels in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Effect of dronedarone on cardiovascular events in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Atrial fibrillation pathophysiology: implications for management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

The novel antiarrhythmic drug dronedarone: comparison with amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Effects of amiodarone and dronedarone on voltage-dependent sodium current in human cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Control of cardiac rhythm by ORK1, a Drosophila two-pore domain potassium channel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

TASK-1 channels may modulate action potential duration of human atrial cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Heterogeneous expression of tandem-pore K+ channel genes in adult and embryonic rat heart quantified by real-time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Proton block and voltage gating are potassium-dependent in the cardiac leak channel Kcnk3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

21 January 2018

Cardiac channelopathies

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Structural models of TREK channels and their gating mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Crystal structure of the human two-pore domain potassium channel K2P1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Multiple mechanisms of hERG liability: K+ current inhibition, disruption of protein trafficking, and apoptosis induced by amoxapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Properties and modulation of mammalian 2P domain K+ channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

The acid-sensitive potassium channel TASK-1 in rat cardiac muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

PKC-dependent activation of human K(2P) 18.1 K(+) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Sumoylation silences the plasma membrane leak K+ channel K2P1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Novel pharmacological approaches for antiarrhythmic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Alternative splicing determines mRNA translation initiation and function of human K(2P)10.1 K+ channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

A specific two-pore domain potassium channel blocker defines the structure of the TASK-1 open pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Alternative translation initiation in rat brain yields K2P2.1 potassium channels permeable to sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

Acute inhibitory effect of dronedarone, a noniodinated benzofuran analogue of amiodarone, on Na+/Ca2+ exchange current in guinea pig cardiac ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

The stretch-activated potassium channel TREK-1 in rat cardiac ventricular muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

The hERG K(+) channel S4 domain L532P mutation: characterization at 37°C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0780-9

KCNK2: reversible conversion of a hippocampal potassium leak into a voltage-dependent channel

21 January 2018

1 reference

12 December 2020

Inhibitory effects of dronedarone on muscarinic K+ current in guinea pig atrial cells

1 reference

12 December 2020

Cellular and in vivo electrophysiological effects of dronedarone in normal and postmyocardial infarcted rats

1 reference

12 December 2020

Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation

1 reference

12 December 2020

High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.

1 reference

12 December 2020

10.1007/S00210-012-0780-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22790794%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference